Trial Profile
Open-label Expanded Access Program on safety measures during the treatment of HIV-1 positive pregnant patients or women who want to become pregnant, with Viracept using the 625-mg tablet
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2010
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications HIV-1 infections; Pregnancy
- Focus Adverse reactions
- Sponsors Roche
- 23 Sep 2008 New trial record.